Skip to main content
Erschienen in: Calcified Tissue International 4/2015

01.04.2015 | Original Research

Unexplained High BMD in DXA-Scanned Patients is Generalized Throughout the Skeleton and Characterized by Thicker Cortical and Trabecular Bone

verfasst von: S. Lomholt, A. K. Amstrup, E. Moser, N. F. B. Jakobsen, L. Mosekilde, P. Vestergaard, L. Rejnmark

Erschienen in: Calcified Tissue International | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Unexplained high bone mineral density (BMD) is a rare condition and the mechanisms responsible are yet to be described in detail. The aim of the study was to identify patients with unexplained high BMD from a local DXA database and compare their radiological phenotype with an age- and a gender-matched group of population-based controls. We defined high BMD as a DXA Z-score ≥ + 2.5 at the total hip and lumbar spine. We characterized the findings as “unexplained” if no osteodegenerative changes, bone metabolic disease, or arthritis at the hip or lumbar spine was observed. All participants were investigated with high-resolution peripheral quantitative computed tomography (HR-pQCT), QCT, DXA, fasting blood samples, a 24-h urine sample, and questionnaires. The DXA database contained data on 25,118 patients. Initially, 138 (0.55 %) potential participants with high BMD were identified, and during the study ten additional cases were identified from new DXA scans. Sixty-seven patients accepted to participate in the study, and among these we identified 15 women and one man with unexplained high BMD. These 15 women had higher BMD throughout the skeleton relative to controls, similar area/volume at the hip and the distal extremities, a higher number of trabeculae, which was thicker than in the controls, and a higher finite element estimated bone strength. The 15 women were heavier and had a higher fat mass then controls. We conclude that patients with unexplained high BMD have a generalized high BMD phenotype throughout their skeleton, which is characterized with a denser microarchitecture.
Literatur
1.
3.
4.
Zurück zum Zitat Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 6:368–381CrossRef Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 6:368–381CrossRef
5.
Zurück zum Zitat Blake GM, Fogelman I (1997) Interpretation of bone densitometry studies. Semin Nucl Med 3:248–260CrossRef Blake GM, Fogelman I (1997) Interpretation of bone densitometry studies. Semin Nucl Med 3:248–260CrossRef
6.
Zurück zum Zitat Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 9588:657–666. doi:10.1016/s0140-6736(07)61342-7 CrossRef Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 9588:657–666. doi:10.​1016/​s0140-6736(07)61342-7 CrossRef
7.
Zurück zum Zitat Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi J, Shea B, Tugwell P, Guyatt G (2002) Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 4:508–516. doi:10.1210/er.2001-2002 CrossRef Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi J, Shea B, Tugwell P, Guyatt G (2002) Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 4:508–516. doi:10.​1210/​er.​2001-2002 CrossRef
8.
Zurück zum Zitat Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 19:1434–1441. doi:10.1056/nejm200105103441904 CrossRef Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 19:1434–1441. doi:10.​1056/​nejm200105103441​904 CrossRef
9.
Zurück zum Zitat Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 8:756–765. doi:10.1056/NEJMoa0809493 CrossRef Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 8:756–765. doi:10.​1056/​NEJMoa0809493 CrossRef
10.
Zurück zum Zitat Gregson CL, Steel SA, O’Rourke KP, Allan K, Ayuk J, Bhalla A, Clunie G, Crabtree N, Fogelman I, Goodby A, Langman CM, Linton S, Marriott E, McCloskey E, Moss KE, Palferman T, Panthakalam S, Poole KE, Stone MD, Turton J, Wallis D, Warburton S, Wass J, Duncan EL, Brown MA, Davey-Smith G, Tobias JH (2012) ‘Sink or swim’: an evaluation of the clinical characteristics of individuals with high bone mass. Osteoporos Int 2:643–654. doi:10.1007/s00198-011-1603-4 CrossRef Gregson CL, Steel SA, O’Rourke KP, Allan K, Ayuk J, Bhalla A, Clunie G, Crabtree N, Fogelman I, Goodby A, Langman CM, Linton S, Marriott E, McCloskey E, Moss KE, Palferman T, Panthakalam S, Poole KE, Stone MD, Turton J, Wallis D, Warburton S, Wass J, Duncan EL, Brown MA, Davey-Smith G, Tobias JH (2012) ‘Sink or swim’: an evaluation of the clinical characteristics of individuals with high bone mass. Osteoporos Int 2:643–654. doi:10.​1007/​s00198-011-1603-4 CrossRef
11.
Zurück zum Zitat Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 1:11–19. doi:10.1086/338450 CrossRef Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 1:11–19. doi:10.​1086/​338450 CrossRef
13.
Zurück zum Zitat Sarrion P, Mellibovsky L, Urreizti R, Civit S, Cols N, Garcia-Giralt N, Yoskovitz G, Aranguren A, Malouf J, Di Gregorio S, Rio LD, Guerri R, Nogues X, Diez-Perez A, Grinberg D, Balcells S (2014) Genetic analysis of high bone mass cases from the BARCOS cohort of Spanish postmenopausal women. PLoS One 4:e94607. doi:10.1371/journal.pone.0094607 CrossRef Sarrion P, Mellibovsky L, Urreizti R, Civit S, Cols N, Garcia-Giralt N, Yoskovitz G, Aranguren A, Malouf J, Di Gregorio S, Rio LD, Guerri R, Nogues X, Diez-Perez A, Grinberg D, Balcells S (2014) Genetic analysis of high bone mass cases from the BARCOS cohort of Spanish postmenopausal women. PLoS One 4:e94607. doi:10.​1371/​journal.​pone.​0094607 CrossRef
14.
Zurück zum Zitat Whyte MP (2005) Misinterpretation of osteodensitometry with high bone density: BMD Z≥ or +2.5 is not “normal”. J Clin Densitom 1:1–6CrossRef Whyte MP (2005) Misinterpretation of osteodensitometry with high bone density: BMD Z≥ or +2.5 is not “normal”. J Clin Densitom 1:1–6CrossRef
15.
Zurück zum Zitat Frost M, Andersen T, Gossiel F, Hansen S, Bollerslev J, van Hul W, Eastell R, Kassem M, Brixen K (2011) Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5. J Bone Miner Res 8:1721–1728. doi:10.1002/jbmr.376 CrossRef Frost M, Andersen T, Gossiel F, Hansen S, Bollerslev J, van Hul W, Eastell R, Kassem M, Brixen K (2011) Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5. J Bone Miner Res 8:1721–1728. doi:10.​1002/​jbmr.​376 CrossRef
16.
Zurück zum Zitat Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 20:1513–1521. doi:10.1056/NEJMoa013444 CrossRef Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 20:1513–1521. doi:10.​1056/​NEJMoa013444 CrossRef
17.
Zurück zum Zitat Gregson CL, Hardcastle SA, Cooper C, Tobias JH (2013) Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management. Rheumatol (Oxford). doi:10.1093/rheumatology/ket007 Gregson CL, Hardcastle SA, Cooper C, Tobias JH (2013) Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management. Rheumatol (Oxford). doi:10.​1093/​rheumatology/​ket007
18.
Zurück zum Zitat Gregson CL, Sayers A, Lazar V, Steel S, Dennison EM, Cooper C, Smith GD, Rittweger J, Tobias JH (2013) The high bone mass phenotype is characterised by a combined cortical and trabecular bone phenotype: findings from a pQCT case-control study. Bone 1:380–388. doi:10.1016/j.bone.2012.10.021 CrossRef Gregson CL, Sayers A, Lazar V, Steel S, Dennison EM, Cooper C, Smith GD, Rittweger J, Tobias JH (2013) The high bone mass phenotype is characterised by a combined cortical and trabecular bone phenotype: findings from a pQCT case-control study. Bone 1:380–388. doi:10.​1016/​j.​bone.​2012.​10.​021 CrossRef
19.
Zurück zum Zitat Jakobsen NF, Rolighed L, Moser E, Nissen PH, Mosekilde L, Rejnmark L (2014) Increased trabecular volumetric bone mass density in familial hypocalciuric hypercalcemia (FHH) type 1: a cross-sectional study. Calcif Tissue Int. doi:10.1007/s00223-014-9877-0 PubMed Jakobsen NF, Rolighed L, Moser E, Nissen PH, Mosekilde L, Rejnmark L (2014) Increased trabecular volumetric bone mass density in familial hypocalciuric hypercalcemia (FHH) type 1: a cross-sectional study. Calcif Tissue Int. doi:10.​1007/​s00223-014-9877-0 PubMed
20.
Zurück zum Zitat Pothuaud L, Carceller P, Hans D (2008) Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone 4:775–787. doi:10.1016/j.bone.2007.11.018 CrossRef Pothuaud L, Carceller P, Hans D (2008) Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone 4:775–787. doi:10.​1016/​j.​bone.​2007.​11.​018 CrossRef
21.
Zurück zum Zitat Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA, Bilezikian JP (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 3:518–530. doi:10.1002/jbmr.2176 CrossRef Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA, Bilezikian JP (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 3:518–530. doi:10.​1002/​jbmr.​2176 CrossRef
23.
Zurück zum Zitat Laib A, Hauselmann HJ, Ruegsegger P (1998) In vivo high resolution 3D-QCT of the human forearm. Technol Health Care 5–6:329–337 Laib A, Hauselmann HJ, Ruegsegger P (1998) In vivo high resolution 3D-QCT of the human forearm. Technol Health Care 5–6:329–337
24.
Zurück zum Zitat Laib A, Ruegsegger P (1999) Calibration of trabecular bone structure measurements of in vivo three-dimensional peripheral quantitative computed tomography with 28-microm-resolution microcomputed tomography. Bone 1:35–39CrossRef Laib A, Ruegsegger P (1999) Calibration of trabecular bone structure measurements of in vivo three-dimensional peripheral quantitative computed tomography with 28-microm-resolution microcomputed tomography. Bone 1:35–39CrossRef
26.
Zurück zum Zitat Laib A, Newitt DC, Lu Y, Majumdar S (2002) New model-independent measures of trabecular bone structure applied to in vivo high-resolution MR images. Osteoporos Int 2:130–136CrossRef Laib A, Newitt DC, Lu Y, Majumdar S (2002) New model-independent measures of trabecular bone structure applied to in vivo high-resolution MR images. Osteoporos Int 2:130–136CrossRef
27.
Zurück zum Zitat van Rietbergen B, Weinans H, Huiskes R, Odgaard A (1995) A new method to determine trabecular bone elastic properties and loading using micromechanical finite-element models. J Biomech 1:69–81CrossRef van Rietbergen B, Weinans H, Huiskes R, Odgaard A (1995) A new method to determine trabecular bone elastic properties and loading using micromechanical finite-element models. J Biomech 1:69–81CrossRef
28.
Zurück zum Zitat Pistoia W, van Rietbergen B, Lochmuller EM, Lill CA, Eckstein F, Ruegsegger P (2002) Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images. Bone 6:842–848CrossRef Pistoia W, van Rietbergen B, Lochmuller EM, Lill CA, Eckstein F, Ruegsegger P (2002) Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images. Bone 6:842–848CrossRef
29.
Zurück zum Zitat Maunsell Z, Wright DJ, Rainbow SJ (2005) Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 9:1683–1690. doi:10.1373/clinchem.2005.052936 CrossRef Maunsell Z, Wright DJ, Rainbow SJ (2005) Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 9:1683–1690. doi:10.​1373/​clinchem.​2005.​052936 CrossRef
30.
Zurück zum Zitat Gregson CL, Paggiosi MA, Crabtree N, Steel SA, McCloskey E, Duncan EL, Fan B, Shepherd JA, Fraser WD, Smith GD, Tobias JH (2013) Analysis of body composition in individuals with high bone mass reveals a marked increase in fat mass in women but not men. J Clin Endocrinol Metab 2:818–828. doi:10.1210/jc.2012-3342 CrossRef Gregson CL, Paggiosi MA, Crabtree N, Steel SA, McCloskey E, Duncan EL, Fan B, Shepherd JA, Fraser WD, Smith GD, Tobias JH (2013) Analysis of body composition in individuals with high bone mass reveals a marked increase in fat mass in women but not men. J Clin Endocrinol Metab 2:818–828. doi:10.​1210/​jc.​2012-3342 CrossRef
32.
Zurück zum Zitat Abrahamsen B, Rohold A, Henriksen JE, Beck-Nielsen H (2000) Correlations between insulin sensitivity and bone mineral density in non-diabetic men. Diabet Med 2:124–129CrossRef Abrahamsen B, Rohold A, Henriksen JE, Beck-Nielsen H (2000) Correlations between insulin sensitivity and bone mineral density in non-diabetic men. Diabet Med 2:124–129CrossRef
33.
Zurück zum Zitat Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJ, Reid IR (2001) Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone 2:162–168CrossRef Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJ, Reid IR (2001) Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone 2:162–168CrossRef
34.
Zurück zum Zitat Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL, Grey AB, Broom N, Myers DE, Nicholson GC, Reid IR (2002) Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 2:405–415CrossRef Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL, Grey AB, Broom N, Myers DE, Nicholson GC, Reid IR (2002) Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 2:405–415CrossRef
36.
Zurück zum Zitat Terzi R, Dindar S, Terzi H, Demirtas O (2014) Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia. Metab Syndr Relat Disord. doi:10.1089/met.2014.0074 PubMed Terzi R, Dindar S, Terzi H, Demirtas O (2014) Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia. Metab Syndr Relat Disord. doi:10.​1089/​met.​2014.​0074 PubMed
37.
Zurück zum Zitat Hernandez JL, Olmos JM, Pariente E, Martinez J, Valero C, Garcia-Velasco P, Nan D, Llorca J, Gonzalez-Macias J (2010) Metabolic syndrome and bone metabolism: the Camargo Cohort study. Menopause 5:955–961. doi:10.1097/gme.0b013e3181e39a15 CrossRef Hernandez JL, Olmos JM, Pariente E, Martinez J, Valero C, Garcia-Velasco P, Nan D, Llorca J, Gonzalez-Macias J (2010) Metabolic syndrome and bone metabolism: the Camargo Cohort study. Menopause 5:955–961. doi:10.​1097/​gme.​0b013e3181e39a15​ CrossRef
38.
Zurück zum Zitat Boutroy S, Van Rietbergen B, Sornay-Rendu E, Munoz F, Bouxsein ML, Delmas PD (2008) Finite element analysis based on in vivo HR-pQCT images of the distal radius is associated with wrist fracture in postmenopausal women. J Bone Miner Res 3:392–399. doi:10.1359/jbmr.071108 Boutroy S, Van Rietbergen B, Sornay-Rendu E, Munoz F, Bouxsein ML, Delmas PD (2008) Finite element analysis based on in vivo HR-pQCT images of the distal radius is associated with wrist fracture in postmenopausal women. J Bone Miner Res 3:392–399. doi:10.​1359/​jbmr.​071108
39.
Zurück zum Zitat Chevalley T, Bonjour JP, van Rietbergen B, Ferrari S, Rizzoli R (2013) Fracture history of healthy premenopausal women is associated with a reduction of cortical microstructural components at the distal radius. Bone. doi:10.1016/j.bone.2013.04.025 PubMed Chevalley T, Bonjour JP, van Rietbergen B, Ferrari S, Rizzoli R (2013) Fracture history of healthy premenopausal women is associated with a reduction of cortical microstructural components at the distal radius. Bone. doi:10.​1016/​j.​bone.​2013.​04.​025 PubMed
40.
Zurück zum Zitat Chevalley T, Bonjour JP, van Rietbergen B, Rizzoli R, Ferrari S (2012) Fractures in healthy females followed from childhood to early adulthood are associated with later menarcheal age and with impaired bone microstructure at peak bone mass. J Clin Endocrinol Metab 11:4174–4181. doi:10.1210/jc.2012-2561 CrossRef Chevalley T, Bonjour JP, van Rietbergen B, Rizzoli R, Ferrari S (2012) Fractures in healthy females followed from childhood to early adulthood are associated with later menarcheal age and with impaired bone microstructure at peak bone mass. J Clin Endocrinol Metab 11:4174–4181. doi:10.​1210/​jc.​2012-2561 CrossRef
Metadaten
Titel
Unexplained High BMD in DXA-Scanned Patients is Generalized Throughout the Skeleton and Characterized by Thicker Cortical and Trabecular Bone
verfasst von
S. Lomholt
A. K. Amstrup
E. Moser
N. F. B. Jakobsen
L. Mosekilde
P. Vestergaard
L. Rejnmark
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
Calcified Tissue International / Ausgabe 4/2015
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-015-9955-y

Weitere Artikel der Ausgabe 4/2015

Calcified Tissue International 4/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.